BIOC - Biocept, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2019
12/30/2018
12/30/2017
12/30/2016
Cash flows from operating activities
Net Income
-25,138
-25,138
-24,572
-21,614
-18,399
Depreciation & amortization
-
-
801
576
322
Stock based compensation
-
-
623
1,247
1,594
Change in working capital
-
-
801
145
749
Accounts receivable
-
-
-381
-1,064
-95
Inventory
-
-
-50
101
-168
Accounts Payable
-
-
602
350
333
Other working capital
-
-
-22,500
-21,051
-16,179
Other non-cash items
-
-
29
46
68
Net cash provided by operating activites
-
-
-22,355
-19,651
-15,697
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-145
-1,400
-482
Net cash used for investing activites
-
-
-145
-1,400
-451
Cash flows from financing activities
Debt repayment
-
-
-1,358
-2,101
-1,238
Common stock issued
-
-
25,693
13,505
13,771
Other financing activites
-
-
-559
-465
-596
Net cash used privided by (used for) financing activities
-
-
23,777
18,588
11,936
Net change in cash
-
-
1,277
-2,463
-4,212
Cash at beginning of period
-
-
2,147
4,609
8,821
Cash at end of period
-
-
3,423
2,147
4,609
Free Cash Flow
Operating Cash Flow
-
-
-22,355
-19,651
-15,697
Capital Expenditure
-
-
-145
-1,400
-482
Free Cash Flow
-
-
-22,500
-21,051
-16,179